Zhan, Peng

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Zheng, Y., Zhuang, M.-W., Han, L., Zhang, J., Nan, M.-L., Zhan, P., Kang, D., Liu, X., Gao, C., & Wang, P.-H. (2020) · Signal Transduction and Targeted Therapy

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 302

HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design

Zhan, P., Chen, X., Li, D., Fang, Z., De Clercq, E., & Liu, X. (2013) · Medicinal Research Reviews

HIV/AIDS drug development and treatmentComputational Drug Discovery Methods

Cited by 192

Recent progress in the research of small molecule HIV-1 RNase H inhibitors

Cao, L., Song, W., Clercq, E., Zhan, P., & Liu, X. (2014) · Current Medicinal Chemistry

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 34

Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles

Wang, Z., Rumrill, S., Kang, D., Guma, S. D., Feng, D., De Clercq, E., Pannecouque, C., Chen, C. H., Arnold, E., Ruiz, F. X., et al. (2025) · Science Advances

HIV/AIDS drug development and treatmentComputational Drug Discovery Methods

Cited by 7